DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rebetol (Ribavirin) - Anaemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Anaemia (270)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rebetol (Ribavirin) where reactions include anaemia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 270   Next >>

Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Pancreatitis Acute, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-06-15

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-06-20

Telaprevir
    Dosage: 2250 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-06-20

Other drugs received by patient: Talion (Bepotastine Besylate); Feburic; Famostagine D; NEO-Minophagen C; Urdeston; Trebianom; Sitagliptin Phosphate



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Renal Impairment, Anaemia, Pancreatitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-27

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-05-24

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-05-25

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-05-17

Other drugs received by patient: Antebate; Prednisolone; Dexaltin; Ubiron; Aspara CA; Loxonin; Onealfa; Diovan; Berizym (Lysozyme Chloride); Mirobect; Amlodipine; Isoleucine (+) Leucine (+) Valine; Lansoprazole; Mucosta



Possible Rebetol side effects in

Reported by a pharmacist from Spain on 2012-08-27

Patient:

Reactions: Anaemia, Neutropenia

Drug(s) suspected as cause:
Pegasys
    Dosage: semanal
    Start date: 2011-09-29

Rebetol
    Dosage: 1200/dia y pegasys semanal.
    Administration route: Oral
    Start date: 2011-09-29



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Anaemia, Blood Uric Acid Increased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 30 microgram per kilogram, qw
    Start date: 2012-07-05

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-06-21

PEG-Intron
    Dosage: 50 microgram per kilogram, qw
    Start date: 2012-07-12

PEG-Intron
    Dosage: 70 microgram per kilogram, qw
    Start date: 2012-07-19

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-06-27

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-07-05

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-06-27

Other drugs received by patient: Theo-DUR; Lendormin; Mucodyne



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.8 microgram per kilogram, qw
    Start date: 2012-05-08

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-24

PEG-Intron
    Dosage: 1.0 microgram per kilogram, qw
    Start date: 2012-05-01
    End date: 2012-05-01

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-07-12

Other drugs received by patient: Claritin; Ferotym; Livalo; Epadel S



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: White Blood Cell Count Decreased, Renal Impairment, Anaemia, Platelet Count Decreased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 mcg /kg/week
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-04-25

PEG-Intron
    Dosage: 1.0 mcg /kg/week
    Start date: 2012-06-26

PEG-Intron
    Dosage: 1.0 mcg /kg/week
    Start date: 2012-04-26
    End date: 2012-06-06

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-06-06

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-06-07

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-06-26
    End date: 2012-07-24

Other drugs received by patient: Motilium; Lorfenamin; Motilium; L Cartin; Rikkunshi-TO; Epadel



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Anaemia, Platelet Count Decreased

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-02-07

Peginterferon Alfa-2B
    Dosage: 1.0 ?g/kg, qw
    Start date: 2012-02-15

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-01-31
    End date: 2012-02-08

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-15
    End date: 2012-07-11

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-02-09
    End date: 2012-02-14

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-04-24

Other drugs received by patient: Ferotym; Epadel S; Etizolam; Norvasc; Depas; Claritin Reditabs; Livalo



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: White Blood Cell Count Decreased, Contusion, Anaemia, Fall, Loss of Consciousness, Haemoglobin Decreased, Anxiety, Dysgeusia, Urine Uric Acid Increased, Disturbance in Attention, Injury, Feeling Abnormal, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qam
    Indication: Hepatitis C
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qpm

Rebetol
    Dosage: unk unk, qam

Rebetol
    Dosage: unk unk, qpm
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qpm

Rebetol
    Dosage: unk unk, qam

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-31



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-25

Patient:

Reactions: Gastrointestinal Haemorrhage, Anaemia, Haematemesis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2011-11-02
    End date: 2012-06-27

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-02
    End date: 2012-05-28

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-05-29
    End date: 2012-06-30

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Start date: 2012-05-14
    End date: 2012-05-22

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-06-30

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-09
    End date: 2012-05-11



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-25

Patient:

Reactions: Anaemia, Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-12

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-07-02

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-07-01

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-12

Other drugs received by patient: Claritin Reditabs Tablets 10 MG; Diltiazem Hydrochloride; Livalo; Epadel S; Ferotym



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-06

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-20

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-06
    End date: 2012-06-19

Telavic
    Dosage: 1500 milligrams, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-06

Other drugs received by patient: Lexotan; Norvasc; Mucosta; Epadel S; Ferotym; Depas; Maglax (Magnesium Oxide); Claritin Reditabs Tablets 10 MG; Livalo



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-24

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-05-10
    End date: 2012-08-02

Rebetol
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2012-07-06
    End date: 2012-07-22

Rebetol
    Dosage: 600 mg, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-10
    End date: 2012-08-02

Rebetol
    Dosage: 800 mg, qd
    Start date: 2012-07-23
    End date: 2012-08-02

Rebetol
    Dosage: 600 mg, qd
    Start date: 2012-08-14

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-07
    End date: 2012-08-06

Other drugs received by patient: Truvada; Metformin Hydrochloride; Losartan Potassium; Procrit; Ondansetron; Fenofibrate; Isentress; Vitamins (Unspecified); Neupogen



Possible Rebetol side effects in 71 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24

Patient: 71 year old male

Reactions: Drug Eruption, Anaemia

Drug(s) suspected as cause:
Pegintron / 01543001 /
    Dosage: 1.5 a?g/kg, unk
    Indication: Hepatitis C
    Start date: 2012-02-15
    End date: 2012-08-02

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2012-03-29

Rebetol
    Dosage: 400 mg, qod
    Administration route: Oral
    Start date: 2012-04-12
    End date: 2012-08-02

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-15
    End date: 2012-02-27

Rebetol
    Dosage: 200 mg, qod
    Administration route: Oral
    Start date: 2012-03-15
    End date: 2012-03-28

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-22
    End date: 2012-04-11

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-02-28
    End date: 2012-03-08

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-09
    End date: 2012-03-14

VX-950
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-15
    End date: 2012-04-26

Other drugs received by patient: Loxonin; Azulene-Glutamine; Urso / 00465701 /



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, unk
    Indication: Hepatitis C
    Start date: 2012-06-02

Rebetol
    Dosage: stop interval: 2 day
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-02
    End date: 2012-06-14

Rebetol
    Dosage: stop interval: 2 day
    Administration route: Oral
    Start date: 2012-06-15

Telavic
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-02

Other drugs received by patient: Claritin Reditabs; Omeprazole; Nifedipine; Ferotym; Allopurinol; Benecid; Livalo; Epadel S; Micardis; Onealfa



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-24

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 microgram, qw
    Indication: Hepatitis C
    Start date: 2008-02-07
    End date: 2008-06-02

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2008-02-07
    End date: 2008-02-28

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2008-02-29
    End date: 2008-03-06

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2008-03-07



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-08-24

Patient:

Reactions: Weight Decreased, Tongue Disorder, Anaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-01-01

PEG-Intron
    Dosage: 120 microgram, qw
    Start date: 2012-01-01

Rebetol
    Dosage: 2x 200 mg in the morning and 200 mg in the evening
    Start date: 2012-08-09

Rebetol
    Dosage: unk unk, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-01-01

Rebetol
    Dosage: 600 mg in the morning and 400 mg in the evening
    Administration route: Oral
    Start date: 2012-01-01
    End date: 2012-08-08

Other drugs received by patient: Vasexten; Januvia; Valsartan and Hydrochlorothiazide; Glucophage; Nobiten



Possible Rebetol side effects in 39 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24

Patient: 39 year old female

Reactions: Anaemia, Rash, Neutrophil Count Decreased

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.5 a?g/kg, unk
    Indication: Hepatitis C
    Start date: 2012-02-17
    End date: 2012-07-05

Peginterferon Alfa-2B
    Dosage: 1.1 a?g/kg, unk
    Start date: 2012-07-20
    End date: 2012-07-26

Peginterferon Alfa-2B
    Dosage: 1.3 a?g/kg, unk
    Start date: 2012-07-27
    End date: 2012-08-02

Peginterferon Alfa-2B
    Dosage: 1.3 a?g/kg, unk
    Start date: 2012-07-06
    End date: 2012-07-19

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-05-25
    End date: 2012-08-02

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-17

VX-950
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-17
    End date: 2012-03-22

VX-950
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-23
    End date: 2012-05-10



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-02-23

Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Start date: 2012-03-29
    End date: 2012-07-12

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-29

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-02-22

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-05-10
    End date: 2012-07-18

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-23
    End date: 2012-02-29

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-03-01

Other drugs received by patient: Atarax; Olopatadine HCL



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Pancreatitis Acute, Amylase Increased, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-29

Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-01
    End date: 2012-03-20

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-03-27

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-01-31
    End date: 2012-03-20

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-01-30

Telavic
    Dosage: 2250 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-29

Telavic
    Dosage: 1500 mg, once
    Administration route: Oral
    Start date: 2012-03-01
    End date: 2012-03-20

Telavic
    Dosage: unk

Other drugs received by patient: Glufast; Glufast; Tamiflu; Zantac; Primperan TAB; Tamiflu; Acetaminophen; Zantac



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Renal Disorder, Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-28

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-28
    End date: 2012-05-10

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-05-11
    End date: 2012-05-31

Rebetol
    Dosage: 200 mg, qd
    Start date: 2012-06-01

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-28
    End date: 2012-05-03

Telavic
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2012-06-01
    End date: 2012-06-21

Telavic
    Dosage: 1500 mg, qd
    Start date: 2012-06-22
    End date: 2012-07-20

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-05-04
    End date: 2012-05-31

Other drugs received by patient: Ferotym; Livalo; Epadel S; Claritin Reditabs



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-13

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-13

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-13

Other drugs received by patient: Ferotym; Epadel S; Livalo; Claritin Reditabs



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Anaemia, Ascites

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-07
    End date: 2012-07-12

PEG-Intron
    Dosage: 50 microgram, qw
    Start date: 2012-07-12
    End date: 2012-07-18

Rebetol
    Dosage: 600 mg, qd (cumulative dose: 8400 mg)
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-07

Rebetol
    Dosage: 400 mg, qd (cumulative dose: 8400 mg)
    Administration route: Oral
    Start date: 2012-07-05
    End date: 2012-07-12

Rebetol
    Dosage: 200 mg, qd (cumulative dose: 8400 mg)
    Administration route: Oral
    Start date: 2012-07-12
    End date: 2012-07-17

Telavic
    Dosage: 1500 mg, qd (cumulative dose: 29250 mg)
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-07-17

Telavic
    Dosage: 2250 mg, qd (cumulative dose: 29250 mg)
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-07
    End date: 2012-06-17

Other drugs received by patient: Motilium; Salagen; Allopurinol; Lansoprazole; Amlodipine; Candesartan Cilexetil



Possible Rebetol side effects in

Reported by a individual with unspecified qualification from Japan on 2012-08-23

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: unk unk, unknown
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-17

Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-04-17

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-05-14
    End date: 2012-05-27

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-05-28

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-17
    End date: 2012-05-13

Other drugs received by patient: Rohypnol; Goodmin; Paxil; Maglax (Magnesium Oxide); Livalo; Sodium Ferrous Citrate; Claritin Reditabs; Rohypnol; Lorazepam; Paxil; Lorazepam; Claritin Reditabs; Seroquel; Seroquel; Epadel; Epadel; Sodium Ferrous Citrate; Toledomin; Toledomin; Livalo; Goodmin; Maglax (Magnesium Oxide)



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-23

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-11

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-20
    End date: 2012-06-26

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-06-12

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-06-13
    End date: 2012-06-19

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-06-27

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-11

Other drugs received by patient: Rabeprazole Sodium; Acetaminophen; Amlodipine Besylate; Acetaminophen



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-23

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-26

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-06-14

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-26

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-26

Other drugs received by patient: Claritin Reditabs Tablets 10 MG; Livalo; Epadel S; Ferotym; Amlodipine Towa



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Anaemia, Decreased Appetite

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-25

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-07

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-25
    End date: 2012-06-06

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-05-24
    End date: 2012-06-13

Telavic
    Dosage: 750 mg, qd
    Start date: 2012-06-14
    End date: 2012-07-18

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-25
    End date: 2012-05-23

Other drugs received by patient: Levofloxacin; Allopurinol; Sulfamethoxazole and Trimethoprim; Azunol (Sodium Gualenate); Antebate



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Renal Disorder, Anaemia

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-04-11

PEG-Intron
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C

PEG-Intron
    Dosage: 1.5mcg/kg/week
    End date: 2012-06-27

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-02-15
    End date: 2012-02-28

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-14

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-07
    End date: 2012-03-12

Rebetol
    Administration route: Oral
    Start date: 2012-05-30
    End date: 2012-06-27

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-04-10

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-11

Rebetol
    Administration route: Oral
    Start date: 2012-04-11
    End date: 2012-05-08

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-02-29

Rebetol
    Administration route: Oral
    Start date: 2012-05-09
    End date: 2012-05-29

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-04-11

Other drugs received by patient: Sodium Ferrous Citrate; Livalo; Epadel S; Claritin Reditabs; Claritin Reditabs; Epadel S; Livalo; Livalo; Livalo; Livalo; Ferotym



Possible Rebetol side effects in

Reported by a pharmacist from United States on 2012-08-23

Patient:

Reactions: Pruritus, Anaemia, Chest Pain, DRY Skin, Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram/0.5 ml, qw

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral

Other drugs received by patient: Vitamins (Unspecified); Cyanocobalamin; Tylenol; Telaprevir



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Anaemia, Rash, Neutrophil Count Decreased, Hyperuricaemia

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.05 ?g/kg, qw
    Start date: 2012-06-05

Peginterferon Alfa-2B
    Dosage: 1.2 ?g/kg, qw
    Start date: 2012-05-15
    End date: 2012-06-04

Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-05-14

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-05-28

Rebetol
    Dosage: 400 unk, unk
    Administration route: Oral
    Start date: 2012-06-26

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-05-29
    End date: 2012-06-25

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-07-16



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.8mcg/kg/week
    Start date: 2012-07-12

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-26
    End date: 2012-07-11

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-26
    End date: 2012-07-04

Rebetol
    Administration route: Oral
    Start date: 2012-07-05
    End date: 2012-07-11

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-26
    End date: 2012-07-11

Telavic
    Administration route: Oral
    Start date: 2012-07-12
    End date: 2012-07-18

Other drugs received by patient: Solyugen F; Loxonin; Famotidine; Kolantyl; Myser (Difluprednate); Lipolac; Clobetasol Propionate; Betamethasone Sodium Phosphate



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017